Report overview
Market Analysis and Insights: Global Skin Cancer Diagnostics and Therapeutics Market
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
The global Skin Cancer Diagnostics and Therapeutics market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.
In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Cancer Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Cancer Diagnostics and Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Cancer Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Cancer Diagnostics and Therapeutics market.
Global Skin Cancer Diagnostics and Therapeutics Scope and Market Size
Skin Cancer Diagnostics and Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Skin Cancer Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.
Segment by Type
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma
Segment by Application
Hospital
Clinic
Cancer Research Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi
Abbott
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
